Manuscripts
Showing 1591 manuscripts.
HIV type 1 genotypic variation in an antiretroviral treatement-naive population in Southern India
Citation
Pachamuthu (Bala) Balakrishnan, Ph.D., Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., Rami Kantor, M.D., Suniti (Daralak) Solomon, M.D., Kenneth H. Mayer, M.D., David Katzenstein, M.D., Bharat Ramratnam, M.D. HIV type 1 genotypic variation in an antiretroviral treatement-naive population in Southern India. AIDS Research and Human Retroviruses. 2005 Apr 01; 21(4):301-5.Year
2005
Journal
AIDS Research and Human Retroviruses
Drug resistance and antiretroviral drug development
Citation
Robert Shafer, M.D., Jonathan M. Schapiro. Drug resistance and antiretroviral drug development. Journal of Antimicrobial Chemotherapy. 2005 Jun 01; 55(6):817-20.Year
2005
Journal
Journal of Antimicrobial Chemotherapy
Statistical methods for HIV dynamic studies in AIDS clinical trials
Citation
Hulin Wu, Ph.D. Statistical methods for HIV dynamic studies in AIDS clinical trials. Statistical Methods In Medical Research. 2005 Apr 01; 14(2):171-92.Year
2005
Journal
Statistical Methods In Medical Research
Ex vivo modeling of the effects of mycophenolic acid on HIV infection: considerations for antiviral therapy
Citation
Rupinderjeet J. Kaur, V. Klichko, David M. Margolis, M.D. Ex vivo modeling of the effects of mycophenolic acid on HIV infection: considerations for antiviral therapy. AIDS Research and Human Retroviruses. 2005 Feb 01; 21(2):116-24.Year
2005
Journal
AIDS Research and Human Retroviruses
Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
Citation
Samir K. Gupta, M.D., Joseph A. Eustace, M.B., M.H.S., Jonathan A. Winston, M.D., Ivy I. Boydstun, M.D., Tejinder S. Ahuja, M.B.B.S., Rudolph Rodriguez, M.D., Karen T. Tashima, M.D., Michelle E. Roland, M.D., Nora Franceschini, M.D., M.P.H., Frank Palella, M.D., Jeffrey L. Lennox, M.D., Paul E. Klotman, M.D., Sharon Appelbaum Nachman, M.D., Stephen D Hall, Ph.D., Lynda Anne Szczech, M.D., M.S.C.E. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases. 2005 Jun 01; 40(11):1559-85.Year
2005
Journal
Clinical Infectious Diseases
HIV-1 pol replication capacity predicts disease progression
Citation
Eric S Daar, M.D., Karen L. Kesler, Terri Wrin, Christos J. Petropoulos, Ph.D., Michael P. Bates, M.D., Alice Lail, Nicholas S. Hellmann, M.D., Edward Gomperts, M.D., Sharyne Donfield, Ph.D. HIV-1 pol replication capacity predicts disease progression. AIDS. 2005 Jun 10; 19(9):871-7.Year
2005
Journal
AIDS
HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages?
Citation
Cecilia M. Shikuma, M.D., Victor G. Valcour, M.D., Silvia Ratto-Kim, Andrew Williams, Scott Souza, Pharm.D., Mariana Gerschenson, Ph.D., Larry Day, M.D., Jerome H. Kim, M.D., M.C., Bruce Shiramizu, M.D. HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages?. Clinical Infectious Diseases. 2005 Jun 15; 40(12):1846-8.Year
2005
Journal
Clinical Infectious Diseases
Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years) in PACTG 219C.
Citation
John J. Farley, M.D., M.P.H., Philimon Gona, Ph.D., Marilyn Jean Crain, M.P.H., M.D., Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., James M. Oleske, M.D., George Seage, Sc.D., M.P.H., Jane C. Lindsey, Sc.D., Ph.D. Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years) in PACTG 219C. Journal of Acquired Immune Deficiency Syndromes. 2005 Apr 01; 38(4):480-487.Year
2005
Journal
Journal of Acquired Immune Deficiency Syndromes
Persistence of Nevirapine Exposure During the Postpartum Period After Intrapartum Single Dose Nevirapine In Addition to Zidovudine Prophylaxis for the Prevention of Mother-to-Child Transmission of HIV-1.
Citation
Tim Roy Cressey, B.Sc., Ph.D., Gonzague A. Jourdain, M.D., Marc Lallemant, M.D., Suparat Kunkeaw, B.Sc., Brooks Jackson, M.D., M.B.A., Edmund Capparelli, Pharm.D., Philippa Musoke, MB ChB, Mark Mirochnick, M.D., Edmund Capparelli, Pharm.D., Mark Mirochnick, M.D. Persistence of Nevirapine Exposure During the Postpartum Period After Intrapartum Single Dose Nevirapine In Addition to Zidovudine Prophylaxis for the Prevention of Mother-to-Child Transmission of HIV-1. Journal of Acquired Immune Deficiency Syndromes. 2005 Mar 01; 38(3):283-288.Year
2005
Journal
Journal of Acquired Immune Deficiency Syndromes